HealthEquity, Inc. — Form 8-K Summary
Business context and reporting period
The filing reports a board appointment, not quarterly or annual operating results. The reported event occurred September 24, 2026; the report was signed September 30, 2026. HealthEquity is a Delaware corporation whose common stock trades on Nasdaq under HQY.
Key financial and related-party information
- The filing provides no revenue, profit, cash flow, margin, debt, or liquidity results.
- During the fiscal year ended January 31, 2026, HealthEquity paid approximately $146,519 to subsidiaries controlled by Moody’s Corporation for ratings services on outstanding bonds and data sets used for internal modeling.
- The company expects to pay Moody’s controlled subsidiaries more than $120,000 in the fiscal year ending January 31, 2027.
- Director compensation amounts are not specified; the appointee will receive standard non-employee director retainers and additional annual equity awards under the company’s policy.
Material changes and management commentary
Effective September 24, 2026, the board appointed Noémie Heuland, Moody’s Chief Financial Officer, as a director and expanded from ten members to eleven. She will serve on the Audit and Risk Committee and the Cybersecurity and Technology Committee. The filing states there is no arrangement or understanding with her or another person underlying the appointment.
Outlook, risks, and unusual items
The disclosed payments to Moody’s controlled subsidiaries are relevant to assessing the relationship between the company and a director who is also Moody’s CFO. The filing does not provide further detail on the services, payment terms, or how potential conflicts are managed. It contains no company earnings guidance or operating outlook.
The filing identifies the event date as September 24, while its attached press release is dated September 30, 2026, and the report was signed September 30.
Important facts for investors to verify
- Review the company’s proxy statement and director-compensation policy for the value and terms of Ms. Heuland’s compensation.
- Check subsequent filings for actual payments to Moody’s controlled subsidiaries and any additional related-party disclosures.
- Confirm the appointment, committee assignments, and timing in the filed press release and later governance disclosures.